Home » Topics » BioWorld

BioWorld
RSS

DYNAGEN TO SELL 1 MILLION SHARES

March 25, 1992

FDA PANEL GIVES PENTYDE A NEW SETBACK

March 24, 1992

APS REGAINS BULK OF JOINT VENTURE

March 24, 1992

INTERFERON TRIALS ADVANCE TO HIV PATIENTS

March 24, 1992

FIRST BOSTON PICK BOOSTS CENTOCOR

March 24, 1992

TV COMMENTS BOOST QUIDEL SHARES

March 24, 1992

PROLEUKIN APPROVED IN FORMER U.S.S.R.

March 24, 1992

IMCLONE EXPLANDS TRIALS OF MELANOMA DRUG

March 24, 1992

AIDS THERAPY TRIALS 'SUGGEST' PROMISE

March 24, 1992

CHIRON T0 USE LIDAK SCID MICE IN HIV TEST

March 24, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...